| Tricyclic cell-penetrating peptides for efficient delivery of functional antibodies into cancer cells O Tietz, F Cortezon-Tamarit, R Chalk, S Able, KA Vallis Nature Chemistry 14 (3), 284-293, 2022 | 70 | 2022 |
| Radiotracers for molecular imaging of cyclooxygenase-2 (COX-2) enzyme O Tietz, A Marshall, M Wuest, M Wang, F Wuest Current medicinal chemistry 20 (35), 4350-4369, 2013 | 51 | 2013 |
| PET imaging of cyclooxygenase-2 (COX-2) in a pre-clinical colorectal cancer model O Tietz, M Wuest, A Marshall, D Glubrecht, I Hamann, M Wang, ... EJNMMI research 6, 1-11, 2016 | 40 | 2016 |
| Synthesis of three 18 F-labelled cyclooxygenase-2 (COX-2) inhibitors based on a pyrimidine scaffold O Tietz, SK Sharma, J Kaur, J Way, A Marshall, M Wuest, F Wuest Organic & biomolecular chemistry 11 (46), 8052-8064, 2013 | 34 | 2013 |
| VCAM-1 targeted alpha-particle therapy for early brain metastases A Corroyer-Dulmont, S Valable, N Falzone, AM Frelin, O Tietz, J Toutain, ... JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM 39, 409-409, 2019 | 33 | 2019 |
| Design, Synthesis, and Evaluation of an 18F‐Labeled Radiotracer Based on Celecoxib–NBD for Positron Emission Tomography (PET) Imaging of Cyclooxygenase‐2 (COX‐2) J Kaur, O Tietz, A Bhardwaj, A Marshall, J Way, M Wuest, F Wuest ChemMedChem 10 (10), 1635-1640, 2015 | 33 | 2015 |
| Systemic α-synuclein injection triggers selective neuronal pathology as seen in patients with Parkinson’s disease WL Kuan, K Stott, X He, TC Wood, S Yang, JCF Kwok, K Hall, Y Zhao, ... Molecular psychiatry 26 (2), 556-567, 2021 | 28 | 2021 |
| A fluorescent molecular imaging probe with selectivity for soluble tau aggregated protein Y Zhao, O Tietz, WL Kuan, AK Haji-Dheere, S Thompson, B Vallin, ... Chemical Science 11 (18), 4773-4778, 2020 | 16 | 2020 |
| Oligonucleotide-functionalized gold nanoparticles for synchronous telomerase inhibition, radiosensitization, and delivery of theranostic radionuclides BM Bavelaar, L Song, MR Jackson, S Able, O Tietz, I Skaripa-Koukelli, ... Molecular pharmaceutics 18 (10), 3820-3831, 2021 | 14 | 2021 |
| An 111 In-labelled bis-ruthenium (II) dipyridophenazine theranostic complex: mismatch DNA binding and selective radiotoxicity towards MMR-deficient cancer cells MR Gill, MG Walker, S Able, O Tietz, A Lakshminarayanan, R Anderson, ... Chemical Science 11 (33), 8936-8944, 2020 | 13 | 2020 |
| Pyrimidine-based fluorescent COX-2 inhibitors: synthesis and biological evaluation O Tietz, J Kaur, A Bhardwaj, FR Wuest Organic & biomolecular chemistry 14 (30), 7250-7257, 2016 | 12 | 2016 |
| Synthesis and assessment of novel probes for imaging tau pathology in transgenic mouse and rat models L McMurray, JA Macdonald, NK Ramakrishnan, Y Zhao, DW Williamson, ... ACS chemical neuroscience 12 (11), 1885-1893, 2021 | 8 | 2021 |
| Design and synthesis of [125I]Pyricoxib: A novel 125I-labeled cyclooxygenase-2 (COX-2) inhibitors O Tietz, J Dzandzi, A Bhardwaj, JF Valliant, F Wuest Bioorganic & medicinal chemistry letters 26 (6), 1516-1520, 2016 | 8 | 2016 |
| Impact of structural alterations on the radiopharmacological profile of 18F-labeled pyrimidines as cyclooxygenase-2 (COX-2) imaging agents O Tietz, A Marshall, C Bergman, M Wuest, F Wuest Nuclear medicine and biology 62, 9-17, 2018 | 7 | 2018 |
| Design, synthesis and in vitro characterization of fluorescent and paramagnetic CXCR4-targeted imaging agents O Tietz, N Kamaly, G Smith, E Shamsaei, KK Bhakoo, NJ Long, ... American journal of nuclear medicine and molecular imaging 3 (4), 372, 2013 | 5 | 2013 |
| Peptides for trans‐blood–brain barrier delivery R Blades, LM Ittner, O Tietz Journal of Labelled Compounds and Radiopharmaceuticals 66 (9), 237-248, 2023 | 4 | 2023 |
| F-18-Labelled radiotracers for molecular imaging of cyclooxygenase-2 (COX-2) expression in cancer O Tietz, M Wang, A Marshall, SK Sharma, J Way, M Wuest, F Wuest JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS 56, S3-S3, 2013 | 4 | 2013 |
| Structure-activity relationship of three F-18-labelled COX-2 inhibitors O Tietz, A Marshall, M Wang, SK Sharma, JD Way, M Wuest, F Wuest JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS 58, S54-S54, 2015 | 1 | 2015 |
| Characterization of a novel pyrimidine-based selective COX-2 inhibitor as a potential radiosensitizing agent for cancer therapy A Marshall, O Tietz, M Wang, M Wuest, F Wuest JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS 56, S50-S50, 2013 | 1 | 2013 |
| An effective delivery platform for nucleic acid therapeutics: Enhanced cancer cell internalization and endosomal escape S Li, O Tietz, AH El-Sagheer, T Brown, KA Vallis Cancer Research 84 (6_Supplement), 5816-5816, 2024 | | 2024 |
